Trademarkia Logo

United Kingdom

£
Registered

on 4 Aug 2021

Last Applicant/ Owned by

Druggability Technologies Holdings, Ltd

70 Sir John Rogerson's Quay, Dublin 2

Dublin, Ireland,

Serial Number

UK00003677329 filed on 4th Aug 2021

Registration Number

UK00003677329 registered on
3rd Dec 2021

Correspondent Information

Script IP Limited

Turnpike House, 18 Bridge Street

Frome,

Somerset,

BA11 1BB

TAVANTA THERAPEUTICS

prescription pharmaceuticals for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals for tre Read More

Classification Information


Class [5]
Pharmaceutical Products


Prescription pharmaceuticals for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals for treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex.

Class [42]
Computer & Software Services & Scientific Services


Scientific, medical and pharmaceutical research and development, namely, development of new pharmaceutical formulations, development of pharmaceutical formulations for efficient drug release, development of clinical uses and treatments for new chemical entities and known pharmaceutical compounds; research and development of new pharmaceutical formulations; research and development of pharmaceutical formulations for efficient drug release; research and development of pharmaceuticals, namely, pharmaceuticals for treating cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; research and development of new chemical entities and known pharmaceutical compounds; research and development of medicines, namely, for the treatment of cancer, multiple sclerosis, cystic fibrosis, tuberous sclerosis complex, and other disease states; scientific investigations for medical purposes; research and development of medicines, namely, new chemical entities and known pharmaceutical compounds.

Mark Details


Serial Number

UK00003677329

Mark Type

Word

Kind of mark

Individual